Onsdag 28 Oktober | 19:01:55 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

BONESUPPORT Q2 - The US growth spurt continues

2023-07-14 10:25:00

Redeye raises its base case for BONESUPPORT following the Q2 2023 report, where our US CERAMENT G sales estimates were once again beaten. We reconsider our long-term sales outlook for CERAMENT G in the US while also assuming that the cannibalization of CERAMENT BVF will be more aggressive than previously expected.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/